|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/00 | |
| C12P 21/08 |
| (11) | Patento numeris | 2710032 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12790362.3 |
| Europos patento paraiškos padavimo data | 2012-05-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/038628 |
| Data | 2012-05-18 |
| (87) | Numeris | WO 2012/162160 |
| Data | 2012-11-29 |
| (30) | Numeris | Data | Šalis |
| 201161488523 P | 2011-05-20 | US | |
| 201261638134 P | 2012-04-25 | US |
| (72) |
BULIK, Dorota, A., US
BOSQUES, Carlos, J., US
COLLINS, Brian, Edward, US
HAINS, Maurice, Gaston, US
WASHBURN, Nathaniel, J., US
MEADOR, James, US
SMITH, Sean, US
BHATNAGAR, Naveen, US
|
| (73) |
Momenta Pharmaceuticals, Inc.,
301 Binney Street, Cambridge, MA 02142,
US
|
| (54) | MODIFIED GLYCOPROTEINS |
| MODIFIED GLYCOPROTEINS |